Cadex Genomics, Corp.

About:

Cadex Genomics develops molecular diagnostic tests to guide cancer treatment.

Website: http://cadexgenomics.com

Twitter/X: CadexGenomics

Description:

Cadex Genomics develops molecular diagnostic assays to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response using simple blood draws. By combining proven approaches to measuring cell-free DNA with cutting edge technology to improve accuracy and sensitivity, Cadex Genomics provides unique insight into therapy response using simple blood draws. Alibrex (TM) is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The assay is optimized to maximize positive predictive value (PPV) and minimize the number of false non-responders.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2018-06-12

Contact Email:

bhaack(AT)cadexgenomics.com

Founders:

Bill Haack, Greg Schafer, Patrick Hall

Number of Employees:

1-10

Last Funding Date:

2019-02-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai